drug · small molecule
patient view →arsenic trioxide 1
Phase 2updated 2mo agoby Medsenic SAS🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for acute promyelocytic leukemia and neoplasm and 33 investigational indications.
targets
Thioredoxin reductase 1, cytoplasmic
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that